Denise Pollard-Knight

Companies

• Mereo BioPharma Group plcBoard member Jun 25, 2024 to now¹
• Mereo BioPharma Group plcChief executive officer Jan 2, 2024 to now²
• ElancoBoard member Mar 20, 2019 to now³
• OncoMedBoard member Jul 17, 2013 to Jun 25, 2018⁴
• ALBIREO PHARMA, INC.Board member Nov 7, 2016 to Jun 20, 2017⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Elanco ELAN105,588 shares⁶$2.5M at $23.59May 21, 2026
• MBMereo BioPharma Group plc MREO808,921 shares⁷$249.4K at $0.31Sep 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• May 21, 2026Granted 12,196 shares of Elanco⁶
• May 21, 2026Granted 4,678 shares of Elanco⁶
• Nov 28, 2025Granted 10,314 shares of Elanco⁸
• Nov 29, 2024Granted 18,169 shares of Elanco⁹
• Sep 13, 2024Sold 60,046 shares at $4.22 of Mereo BioPharma Group plc⁷
• Sep 12, 2024Sold 28,611 shares at $4.47 of Mereo BioPharma Group plc⁷
• Sep 11, 2024Exercised options 188,060 shares of Mereo BioPharma Group plc¹⁰
• Jun 26, 2024Sold 92,273 shares at $3.39 of Mereo BioPharma Group plc¹¹
• Jun 25, 2024Sold 40,712 shares at $3.69 of Mereo BioPharma Group plc¹¹
• Jun 21, 2024Exercised options 282,090 shares of Mereo BioPharma Group plc¹²
• Nov 30, 2023Granted 20,374 shares of Elanco¹³
• Nov 30, 2022Granted 18,649 shares of Elanco¹⁴
• Nov 30, 2021Granted 7,307 shares of Elanco¹⁵